Yield losses, compliance deviations, high inspection burdens, and fragile supply chains often originate from early product or process design decisions made years before commercial production.
The IDOV Operational Excellence Model (Identify–Design–Optimize–Verify) addresses this challenge by shifting operational excellence upstream—where the greatest leverage exists. Instead of fixing unstable systems later, IDOV enables organizations to design products, processes, and operating models that are inherently capable, compliant, scalable, and economically robust from the start.
Checkout the full post below…
Most operational excellence programs focus on improving processes after problems appear.
But in industries like pharma, medical devices, and life sciences sector in general, the most persistent issues—deviations, yield loss, rising COGS, and supply constraints—are often designed into the system long before production begins.
This is where the IDOV Operational Excellence Model (Identify–Design–Optimize–Verify) becomes powerful.
IDOV is an advanced Design for Six Sigma (DFSS) framework that shifts operational excellence upstream, enabling organizations to design systems that are:
- inherently capable
- compliant by design
- scalable for future demand
- economically robust across the lifecycle
In this post I explore:
- Why traditional OpEx models often address symptoms rather than root causes
- How the four phases of IDOV create robust operating systems
- When leaders should choose IDOV over traditional improvement frameworks
- How IDOV supports Quality by Design and regulatory readiness
IDOV Operational Excellence Model: Designing Capability, Quality, and Economics into the System
Operational excellence programs traditionally concentrate on improving existing processes. Frameworks such as Lean, PDCA, and DMAIC are powerful when the goal is to stabilize performance, eliminate waste, and reduce variation in an established system.
However, in highly regulated, capital-intensive industries such as pharmaceuticals, medical devices, prosthetics, and the broader life sciences sector, the most persistent operational problems are rarely operational in nature.
They are structural.
Quality deviations, chronic yield loss, escalating cost of goods, inspection-heavy operations, and supply fragility are often the downstream consequences of design decisions made years earlier—during product development, technology transfer, or process architecture design.
By the time these issues surface in commercial manufacturing, organizations typically deploy continuous improvement programs, remediation projects, and CAPA cycles to manage the symptoms.
But the root cause remains unchanged.
This is precisely the gap addressed by the IDOV Operational Excellence Model (Identify–Design–Optimize–Verify)—a design-led approach within Design for Six Sigma (DFSS) that focuses on engineering operational excellence into the system from the outset.
Rather than improving unstable systems after the fact, IDOV enables organizations to create products, processes, and operating models that are inherently capable, compliant, and economically sustainable.
The Strategic Role of IDOV in Operational Excellence
IDOV represents a shift from reactive improvement to proactive design.
While traditional operational excellence models focus on process correction, IDOV focuses on system creation.
This distinction becomes critical when organizations are:
- Launching new products
- Designing new manufacturing platforms
- Scaling supply networks
- Transferring technology to commercial operations
- Responding to future regulatory expectations
- Preparing for long-term market demand
When applied correctly, IDOV allows organizations to embed:
- Quality by Design (QbD) principles
- Robust process capability
- Lifecycle economic performance
- Regulatory defensibility
- Scalable operational architecture
When Leaders Should Choose the IDOV Model
Decisionmakers should consider deploying IDOV when design decisions will determine long-term operational performance.
Typical scenarios include:
1. New product introductions- When launching new products, early design choices determine future yield, manufacturability, and compliance risk.
3. Process or platform redesign- In some cases, existing processes simply cannot meet future demand, cost targets, or regulatory expectations. Incremental improvement becomes insufficient.
4. Strategic manufacturing transformation- Organizations seeking to modernize manufacturing—through automation, digitalization, or platform technologies—benefit from a design-led approach that integrates quality, cost, and scalability simultaneously.
In each of these situations, the leadership question is simple: Are we trying to improve the current system, or should we design a better one?
IDOV is the model for the latter.
The Four Phases of the IDOV Model
The strength of IDOV lies in its structured yet design-centric methodology. Each phase builds progressively toward a solution that is technically robust, economically viable, and operationally scalable.
1. Identify
Defining the Right Problem and the Right Outcomes. The Identify phase establishes strategic clarity before design begins.
Rather than focusing narrowly on technical specifications, this phase aligns the solution with business objectives, patient needs, regulatory expectations, and lifecycle economics.
Key activities include:
- Defining Critical-to-Quality (CTQ) attributes
- Identifying Critical-to-Cost (CTC) drivers
- Establishing Critical-to-Time (CTT) requirements
- Understanding future demand and market dynamics
- Identifying regulatory and compliance constraints
- Developing value hypotheses around Cost of Poor Quality (COPQ), COGS reduction, and supply resilience
Misalignment here leads to design efforts that optimize the wrong outcomes.
2. Design
Creating Solutions That Meet Requirements by Design. During the Design phase, teams generate solution architectures capable of meeting performance requirements inherently.
This stage focuses on eliminating potential failure modes during design, rather than detecting them later through inspection.
Typical activities include:
- Developing alternative product and process concepts
- Embedding Quality by Design principles
- Defining control strategies and measurement systems
- Designing for manufacturability and scale
- Integrating compliance requirements into process architecture
- Evaluating automation and inspection strategies
Designs that rely heavily on inspection or intervention are rarely robust.
3. Optimize
Engineering Robustness, Capability, and Economics. The Optimize phase represents one of the defining characteristics of the IDOV model.
Here, teams refine the design through structured experimentation, modeling, and simulation, ensuring the system performs reliably under real-world variation.
Key methods include:
- Design of Experiments (DOE)
- Sensitivity and tolerance analysis
- Simulation and modeling
- Throughput and yield optimization
- Cost and capacity optimization
- Supply chain and automation strategy refinement
The leadership question guiding this phase becomes: Will this system remain robust as demand grows, regulations evolve, and operational variability emerges?
Robust systems anticipate variability rather than react to it.
4. Verify
Proving the Design Works in Reality. The Verify phase confirms that the optimized design performs as expected under real operating conditions.
This stage ensures that the system is ready for transfer to routine operations and regulatory scrutiny.
Key activities include:
- Engineering and pilot runs
- Performance and stress testing
- Verification of CTQs and economic targets
- Finalization of control strategies
- Readiness for cGMP operation and regulatory review
Verification ensures the answer is yes.
Why IDOV Represents a High-Maturity Operational Excellence Model
The advantages are significant:
- Reduced deviations and CAPAs
- Lower lifecycle cost of quality
- Inspection-light, capability-heavy operations
- More reliable scale-up and technology transfer
- Improved regulatory defensibility
- Greater supply chain resilience
IDOV vs DMADV OpEx Models: Both Design for Six Sigma Approaches
Where DMAIC improves a process and DMADV designs a product, IDOV designs the entire operating solution—including process architecture, control strategy, and economic performance.
IDOV is a more modern, rapid approach within DFSS that concentrates on optimizing for robustness before validation, whereas DMADV is a more traditional, comprehensive approach focusing on a data-driven transition from analysis to design.
The table below highlights key differences between IDOV and DMADV operational excellence models-
The most advanced organizations understand that operational excellence cannot rely solely on continuous improvement.
Continuous improvement optimizes the system that exists.
Design excellence determines whether the system was capable in the first place.
The IDOV model provides a structured way to ensure that products, processes, and operating models are designed with:
- Quality
- Scalability
- Economic efficiency
- Regulatory robustness
- Lifecycle sustainability
In industries where patient safety, regulatory compliance, and supply reliability are non-negotiable, this design-led approach (which significantly reduces lifecycle risk) is not merely advantageous. It is essential!
Designing robust operational systems requires more than process improvement tools—it requires design-led operational thinking.
If your organization is:
- launching a new product or manufacturing platform
- preparing for technology transfer or scale-up
- redesigning processes to improve quality, cost, and capacity
- integrating Operational Excellence with Quality by Design (QbD)
I work with life sciences and manufacturing organizations to implement design-driven operational excellence frameworks such as IDOV, DMADV and DFSS Hybrid, helping teams build systems that are capable, compliant, and economically sustainable from day one.
Feel free to connect if you’d like to discuss advisory support, transformation programs, or capability-building workshops.
About the author:
Dr. Shruti Bhat is an Advisor in Operational Excellence and Business Continuity Across Pharma and MedTech Value Chains (end-to-end).
Keywords and Tags:
#OperationalExcellence #DesignForSixSigma #DFSS #QualityByDesign #PharmaManufacturing #LifeSciencesManufacturing #MedTechInnovation #LeanSixSigma #ProcessDesign #ManufacturingStrategy #ContinuousImprovement #ManufacturingLeadership #OperationalStrategy #ProcessOptimization #Industry40 #MedTech #LeanSixSigma #ManufacturingExcellence
Categories: Operational Excellence | Life Science Industry | OpEx Models
Follow Shruti on YouTube, LinkedIn
Subscribe to Operational Excellence Academy YouTube channel: |